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Abstract
Tight regulation of transposition activity is essential to limit damage transposons may cause by generating potentially 
lethal DNA rearrangements. Assembly of a bona fide protein-DNA complex, the transpososome, within which 
transposition is catalysed, is a crucial checkpoint in this regulation. In the case of IS911, a member of the large IS3 
bacterial insertion sequence family, the transpososome (synaptic complex A; SCA) is composed of the right and left 
inverted repeated DNA sequences (IRR and IRL) bridged by the transposase, OrfAB (the IS911-encoded enzyme that 
catalyses transposition). To characterise further this important protein-DNA complex in vitro, we used different tagged 
and/or truncated transposase forms and analysed their interaction with IS911 ends using gel electrophoresis. Our 
results allow us to propose a model in which SCA is assembled with a dimeric form of the transposase. Furthermore, we 
present atomic force microscopy results showing that the terminal inverted repeat sequences are probably assembled 
in a parallel configuration within the SCA. These results represent the first step in the structural description of the IS911 
transpososome, and are discussed in comparison with the very few other transpososome examples described in the 
literature.
Introduction
Transposons are ubiquitous. They have had and continue
to exert a major effect on genome architecture, gene
expression and organisation. Tight regulation of their
activity is essential to limit damage they may cause by
generating potentially lethal DNA rearrangements.
Indeed, their study has provided many examples of judi-
cious regulatory mechanisms that are used to achieve this
[1].
A crucial checkpoint in transposition is the assembly of
the 'transpososome'. This step is a general prerequisite for
initiating DNA cleavage and the subsequent chemical
steps in transposition, for most elements that use a DNA
transposition intermediate. In this protein-DNA com-
plex, both ends of the transposon are bridged by an ele-
ment-specific enzyme, the transposase, which catalyses
the DNA strand cleavages and strand transfers necessary
for transposon mobility [2]. The transpososome adopts
very precise architectures to accomplish these steps, and
undergoes defined changes throughout the transposition
process. Such conformational changes have been
observed within the transpososome of IS50  [3-5], the
bacteriophage Mu (which requires three of four specific
transposase binding sites) [6] and Tn10 (whose transpo-
sosome shows an increase in stability as it assembles)
[7,8]. Moreover, for both IS50  and Mu, a transposase
molecule binds to one end but is catalytically active only
on the other transposon end. This arrangement ensures
that cleavage does not occur [6] before the correct com-
plex has been assembled [9,10]. In spite of its key impor-
tance, the composition and organisation of such
assemblies have been examined for only a handful of
transposable elements [2,11] and with varying degrees of
detail.
In this study, we examined the transposition properties
of the bacterial insertion sequence, IS911 [12]. Bacterial
insertion sequences (IS) are among the smallest autono-
mous transposable elements. IS911 belongs to the largest
known family of ISs, the IS3  family (ISfinder: http://
www-is.biotoul.fr). The distinguishing feature of these
compared with other well-known ISs is that they undergo
transposition through replicative excision and conserva-
tive integration (Figure 1a). First, an asymmetric attack of
one end by the other leads to the formation of a single-
strand bridge between the ends. This resembles a nascent
replication fork, which is presumably involved in assem-
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bly of a replication apparatus. Replication generates a
covalently closed circular copy of the IS in which the left
and right ends are abutted and separated by 3-4 bp of
DNA originally flanking the IS. The transposon circle
subsequently undergoes integration into a target mole-
cule. It is now clear that this mechanism is very wide-
spread and has been adopted not only by members of the
IS3 family but also by many additional IS families [13-15].
The overall pathway of IS911 transposition (Figure 1a)
implies the consecutive assembly of two types of transpo-
sosome: one ensuring formation of the single-strand
bridge (synaptic complex A; SCA) and a second (synaptic
complex B; SCB) ensuring integration of the IS into the
target DNA. In this paper, we address the stoichiometry
of the IS911  transposase in the formation of the first
transpososome, the SCA. Moreover, we show that a
dimer of a truncated form of the transposase (containing
the DNA binding but not the catalytic domain), assem-
bles two copies of a DNA fragment including a terminal
inverted repeat sequence (IRR) in a parallel orientation.
Materials and methods
Bacterial strains, media, plasmids and oligonucleotides
The Escherichia coli strains used were JS238, DH5α and
Bl21DE3, as previously described [16]. Cultures were
grown in Luria broth supplemented, when necessary,
with the appropriate antibiotics. Selection was on Luria
agar plates supplemented with the appropriate antibiot-
ics: ampicillin (Ap, 100 μg/ml), tetracycline (Tc, 15 μg/
ml).
Plasmid pAPT166 was used as a substrate to amplify
IRR-100, 150 and 250 DNA fragments [17]. The
pET32b::AB149 plasmid was obtained by insertion of an
NcoI-BamHI PCR DNA fragment containing the
orfAB149 (amplified from pLH114 [18]) into the pET32a
vector (Novagen). Plasmids pLH114 and pET32b::AB149
were used to prepare OrfAB[1-149] and TrxA-OrfAB[1-
149] respectively.
The oligonucleotides used are detailed in Table 1.
Figure 1 IS911 genetic organisation transposition pathway. (A) 
IS911, donor DNA and target DNA are represented as bold, fine and 
dotted lines respectively. Small dark circles represent the two inverted 
repeats (IRs). Grey ellipses represent OrfAB: note that the stoichiometry 
is not shown. Arrows represent strand cleavage and transfer reactions 
that take place within the synaptic complex (SCA) or paired end com-
plex (PEC). IS911 insertion is drawn as a nontargeted pathway 
[16,31,32]. In the synaptic complex B (SCB), proteins are represented as 
grey ellipses without implying OrfAB stoichiometry or the presence or 
absence of OrfA in the complex. (B) Inverted repeat left and right (IRL, 
IRR) sequences: orfA (translational phase 0) and orfB (phase -1). pIRL is 
indicated, and the frameshift site is shown as a dotted line. HTH motifs 
are designated as grey ovals and LZ motifs as an ellipse for each hep-
tad. The M and DDE domains are also indicated. Domains present in 
both OrfA (100 aa) and OrfAB (382 aa) are indicated by light grey, and 
those in OrfAB alone by dark grey (see text). The two designed protein 
variant used in this study OrfAB1-149 (149 amino acids (aa)) and TrxA-
OrfAB1-149 (308 aa) are represented. The dark box represents the TrxA 
tag. (c) Nucleotide sequence of the terminal IRL and IRR. Conserved nu-
cleotides are shown on a grey background. The DNaseI footprint of Or-
fAB[1-149] is indicated schematically above and below the 
sequences[21].
Table 1: Oligonucleotides used.
Primer Sequence 5'3'
IRRa TGAAGTGGTCAACAAAAACTGGCCACCGAGTTAGAG
IRRb CTCTAACTCGGTGGCCAGTTTTTGTTGACCACTTCA
O5 GATACTGGAAAAAACTCTAACTCGG
O6 GAATGGACGATATCACTTCCATGACG
O7 TCAACGCATATAGCGCTAGCAGCACG
O200 GAGCCCGTCAGTATCGGCGGAARousseau et al. Mobile DNA 2010, 1:16
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DNA procedures
S ta nda r d t ec hniques  we r e used f or  DNA m ani pula t ion
and cloning [19]. Restriction and DNA-modifying
enzymes were purchased from New England Biolabs (Ips-
wich, MA, USA). DNA was isolated from agarose gels
using a gel extraction kit (QiaQuick; Qiagen, Hilden, Ger-
many) and PCR products were purified using a PCR puri-
fication kit (QiaQuick; Qiagen), with plasmid DNA was
extracted (Miniprep or Maxiprep kits; Qiagen).
IRR 36 corresponds to the exact sequence of IRR, and
was generated by oligonucleotide hybridisation between
IRRa and IRRb. IRR 100 was generated by PCR from
pAPT166 using the O5 and O6 oligonucleotides to give a
DNA fragment composed as follows: 5'-14 bp internal
flanking DNA-36 bpIRR-50 bp flanking external DNA.
IRR 150 was generated by PCR from pAPT166 using the
O5 and O7 oligonucleotides to give the DNA fragment:
5'-14 bp internal flanking DNA-36 bpIRR-100 bp flanking
external DNA. IRR 250 was generated by PCR from
pAPT166 using the O200 and O6 oligonucleotides to give
the following DNA fragment: 5'-164 bp internal flanking
DNA-36 bp IRR-50 bp flanking external DNA.
Purification of OrfAB[1-149] and TrxA-OrfAB[1-149]
OrfAB[1-149] was prepared as described previously [18].
TrxA-OrfAB[1-149] was expressed in a BL21DE3 deriva-
tive strain from pET32a::AB149. The purification proce-
dure was the same as for OrfAB[1-149] with the following
modifications: lysis was performed in HED0.2K10I buffer
(Hepes 250 mM ph7.5, KCl 0.2M, dithiothreitol (DTT)
1mM, EDTA 1 mM, imidazole 10 mM), and DEAE chro-
matography and ammonium sulfate precipitation steps
were replaced by a classical nickel-nitrilotriacetic acid
(NiNTa) chromatography method, where the protein is
eluted with an imidazole gradient (Qiagen).
Electromobility shift assay
DNA fragments containing IRR were generated by PCR
(IRR-100 [16]) or oligonucleotide hybridisation (IRR-36,
IRRa + IRRb heated together at 98°C for 5 minutes and
cooled to room temperature overnight) and end-labeled
with γ32PATP using a classic kinase reaction). For electro-
mobility shift assay (EMSA) [18], 5 nM of the DNA frag-
ments were incubated with OrfAB[1-149] and/or TrxA-
OrfAB[1-149] in a final volume of 8 μl. Complexes were
separated in a 5% polyacrylamide gel in Tris-glucose-
EDTA (TGE) buffer (12 V/cm at 4°C) for 3 hours. The
results were quantified using ImageGauge software (Fuji,
Tokyo, Japan).
Atomic force microscopy imaging
The sample (in 14 nM DNA R250, 300 nM orfAB149, 25
mM Hepes pH7.5, 200 mM KCl, 1 mM DTT, 1 mM
EDTA, 10% glycerol) was incubated at 37°C for 30 min
before being diluted 1:10 in atomic force microscopy
(AFM) buffer (5 mM Hepes pH7.5, 10 mM MgCl2) and
immediately deposited on freshly cleaved mica that had
just been pretreated with 0.1 mg/mL polylysine (Sigma-
Aldrich, Missouri, MO, USA). After 30 seconds of incu-
bation, the mica was rinsed with an extensive flow of
water and dried under N2. Imaging was performed in air
using an atomic force microscope (Bioscope II; Veeco
Instruments, Palaiseau, France) operating in tapping
mode, with silicon tips (PPP-NCH-50; Nanosensors,
Neuchatel, Switzerland). DNA contours were drawn
manually and their length measured using in-house soft-
ware (Labview).
Results
OrfAB149 binds a 36 bp IRR DNA fragment
Figure 1b illustrates the organisation of IS911, which is
bordered by short (36 bp) terminal inverted repeats (IR).
The transposase, OrfAB, is produced from two reading
frames orfA  and orfB  by programmed -1 translational
frameshifting. The product of the orfA frame, OrA (100
aa), is a regulator of transposition. Production of OrfAB
(292 aa) alone can be accomplished by inserting a single
base pair into the frameshift region to artificially fuse the
A and B frames without any change in the OrfAB amino
acid sequence [20]. We used a derivative of OrfAB,
OrfAB[1-149], truncated for its catalytic (DDE) domain
but including the N-terminal specific DNA binding
domain (helix-turn-helix; HTH) and multimerisation
domains (leucine zipper (LZ); multimerisation (M) [18])
as shown in Figure 1b. Indeed, in our DNA-binding assay
(electrophoretic mobility shift assay; EMSA), the full-
length OrfAB transposase does not efficiently form stable
and specific DNA-protein complexes whereas the trun-
cated form OrfAB[1-149] does [18,21]. This is presum-
ably due to the fact that the OrfAB DNA binding domain
is masked by the natural C-terminal catalytic domain
after folding (Duval-Valentin et al., in preparation). Previ-
ous DNase I protection experiments have demonstrated
that the truncated form, OrfAB[1-149], binds the 36 bp
IS911 terminal IRs [21]. Furthermore EMSA experiments
performed with different IRRs containing DNA frag-
ments (100 to 150 bp in size) have shown that OrfAB[1-
149] assembles large DNA-protein complexes [22].
Finally, using a mixture of two DNA fragments of differ-
ent sizes, one of these large DNA-protein complexes was
previously shown to include two DNA fragments, and is
considered as a valid model for the SCA [22].
Figure 2a shows the results of an EMSA experiment
using a radiolabeled 36 bp oligonucleotide, the precise
right end of the IR (IRR), including the entire transposase
binding site. We used this minimal fragment to avoid
potential additional migratory effects due to the presence
of flanking DNA. Only a single complex was observed.Rousseau et al. Mobile DNA 2010, 1:16
http://www.mobilednajournal.com/content/1/1/16
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The titration experiment (Figure 2a, lanes 2-5) indicated
that the truncated OrfAB[1-149] binds less efficiently to
this 36 bp IRR fragment than to the longer fragments (≥
100 bp) [22](see also Figure 3, lane 4). This suggests that
flanking DNA sequences included in the longer fragment
are important in stabilising OrfAB[1-149] binding [22],
probably by providing (nonspecific) interactions. Fur-
thermore, the appearance of only a single retarded spe-
cies suggests that the DNA fragment containing only IRR,
unlike longer DNA fragments ([22] and below), may be
too short to form a synaptic complex with two DNA cop-
ies. This implies that flanking DNA is not only important
for interaction with OrfAB[1-149] but also for allowing
synapse formation.
OrfAB[1-149] binds IRR as a dimer
To determine the stoichiometry of OrfAB[1-149] in this
complex, we engineered a derivative including an N-ter-
minal TrxA-tag (see Materials and Methods). The molec-
ular weight of OrfAB[1-149] was thus increased from
16.4 kDa to 33.9 kDa. We used this protein together with
OrfAB[1-149] in EMSA experiments (Figure 2b). The
effect of increasing the mass of OrfAB[1-149] in the
TrxA-OrfAB[1-149] derivative is clearly observable by its
enhanced retardation of the protein-DNA complex (com-
pare Figure 2b, lanes 2 and 3). Moreover, when both pro-
Figure 3 OrfAB[1-149] synapses right inverted repeat (IRR) (100 
bp) as a dimer. Electromobility shift assay (EMSA) analysis of the bind-
ing of OrfAB[1-149] (dark ball) and TrxA- OrfAB[1-149] (dark ball with a 
tag) to a 100 bp fragment composed of IRR and flanking DNA (large 
and small grey cylinders respectively). Radiolabeled IRR containing 
DNA fragments (20 nM) were incubated with OrfAB[1-149] and/or 
TrxA-OrfAB[1-149] (final protein concentration of 500 nM in lanes 2-4). 
Reactions were separated in 5% native polyacrylamide gels (12 V/cm), 
and at least six complexes (from complexes I-VI) visualised. A model for 
complex stoichiometry is proposed and discussed in the text.
Figure 2 OrfAB[1-149] binds right inverted repeat (IRR) (36 bp) as 
a dimer. (A) EMSA analysis of the binding of OrfAB[1-149] (dark circle) 
to a 36 bp IRR without any flanking DNA (grey cylinder). Radiolabeled 
IRR containing DNA fragments (5 nM) were incubated with increasing 
amounts of OrfAB[1-149] (0.06, 0.125, 0.25 and 0.5 μM). Reactions were 
separated in 5% native polyacrylamide gels (12 V cm) and only one 
complex (I) is visualised. (B) EMSA analysis of the binding of OrfAB[1-
149] (dark ball) and TrxA-OrfAB[1-149] (dark ball with a tag) to a 36 bp 
IRR without any flanking DNA (grey cylinder). Radiolabeled IRR contain-
ing DNA fragments (5 nM) were incubated with OrfAB[1-149] and/or 
TrxA- OrfAB[1-149] (the final protein concentration is 125 nM in lanes 
2-4). Reactions were separated on 5% native polyacrylamide gels (12 
Vcm-1) and complexes I, II and III are visualised. A model for complexes 
stoichiometry and molecular weight is proposed. (C) The panel repre-
sents a plot of the migration (mm) of the complexes in the gel as a 
function of the logarithm of their theoretical molecular weight as pro-
posed in A.Rousseau et al. Mobile DNA 2010, 1:16
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tein derivatives were included in the reaction mixture, a
single complex of intermediate migration could be
observed in addition to the high and lower retarded com-
plexes generated, respectively, by TrxA-OrfAB[1-149]
and OrfAB[1-149] alone (Figure 2b, lane 4). Note that this
result required that the two proteins be pre-incubated
together before addition of the DNA. The result is for-
mally consistent with the idea that OrfAB[1-149] binds as
a dimer. Moreover when we plotted the logarithm of the
predicted molecular mass of the different protein-DNA
complexes, based on a 'protein dimer hypothesis', as a
function of the migration distance in the electrophoresis
g e l ,  w e  o b t a i n e d  a  l i n e a r  r e l a t i o n s h i p  ( F i g u r e  3 b )  [ 2 3 ] .
This observation reinforces the idea that the observed
DNA-protein complexes are composed of protein dimers.
OrfAB[1-149] pairs IRR as a dimer
The use of a longer (100 bp) IRR-carrying DNA fragment
generated a more complex retardation pattern (Figure 3).
Previous results using OrfAB[1-149] together with a lon-
ger IR-containing DNA fragment have shown that the
SCA can be detected at relatively low protein concentra-
tions, and that increasing OrfAB[1-149] in the reaction
mixture generated a complex that migrated slightly faster
and that is thought to carry only one DNA fragment (as
judged by its behavior when a mixture of fragments of
two lengths is used) [22] (Figure 3, lane 4; complexes II
and III). The TrxA-OrfAB[1-149] derivative under these
conditions generated at least two complexes: relatively
high levels of complex I and a very low level of complex
VI (Figure 3, lane 2). We propose that complex I is com-
posed of a TrxA-OrfAB[1-149] monomer bound to IRR,
whereas complex VI is the synaptic complex. This sug-
gests that TrxA-OrfAB[1-149] binds poorly as a dimer on
DNA fragments longer than 36 bp. This may reflect steric
hindrance by the Trx tag and flanking DNA. Note that
OrfAB[1-149] also forms a small amount of a complex on
the 100 bp DNA fragment (located between complex I
and free DNA; Figure 3, lanes 3 and 4), which might cor-
respond to a DNA-bound monomer. A mixture of both
proteins led to the loss of visible TrxA-OrfAB[1-149]
complexes, again reinforcing the idea that TrxA-
OrfAB[1-149] alone binds poorly as a dimer on the IRR-
containing 100 bp DNA fragment. Two novel complexes
were observed (Figure 3, lane 3), consistent with a mixed
OrfAB[1-149]/TrxA-OrfAB[1-149] dimer bound to one
(complex IV) or two (complex V) DNA fragments. More-
over, the intensity of these bands suggests that TrxA-
OrfAB[1-149] binding is enhanced when combined with
OrfAB[1-149]. We note that the flanking DNA appears to
contribute to the migration properties of the complex in
such a way that they no longer migrate as a function of
the mass of the complex. This is presumably because the
flanking DNA interacts with the protein and changes the
overall shape of the complex [24]. We did not attempt to
identify the minor bands.
Parallel alignment of IRR DNA in SCA formed with OrfAB[1-
149]
To obtain information on the architecture of the synaptic
complex resulting from OrfAB[1-149] binding SCA (Fig-
ure 1a), we used AFM to image DNA fragments of 250 bp
carrying IRR in the presence or in absence of the protein.
In the absence of protein, we observed many DNA mol-
ecules spread over the entire field of the mica surface
(Figure 4a, left panel). The contour length from one end
to the other of the individual molecules was 90 ± 15 nm
(n = 283), which is compatible with the theoretical size of
the DNA molecules (250 bp = 83nm, Figure 4c, Figure
4d). In fact, it is known that in the conditions used here,
AFM imaging of DNA molecules overestimates the real
size [25].
When OrfAB[1-149] was added to the DNA solution at
the same concentration before deposition on mica (Fig-
ure 4a, right panel), many DNA molecules could also be
observed (n = 272) but 24% of these were found to cross
each other compared with only 6% in the absence of pro-
tein. Although the protein was not always clearly visible
on these 'crossed' DNA molecules, we believe that they
are indeed OrfAB[1-149]-mediated DNA synapses.
The DNA molecules used here were asymmetric with
respect to the 20-25 bp OrfAB binding site [21], which
was located at a distance of 66 bp (22 nm) from the clos-
est DNA end (Figure 4c). This asymmetric arrangement
in principle permits determination of the relative orienta-
tion of the two DNA molecules in the synaptic complex.
The distance from the intersection point to the shortest
end (Lse) of the crossed molecules was found to be 31 ±
14 nm (n = 78), in good agreement with that expected for
OrfAB[1-149]-mediated synapses (Figures 4b, Figure 4c).
A more detailed analysis of the length of the arms in the
sample of 78 crossed molecules revealed two morpholo-
gies. The majority (n = 64) were composed of DNA mole-
cules aligned in a parallel fashion whereas the other 14
appeared to be organised as antiparallel complexes. Of
those aligned in parallel, 38 had an X configuration (Fig-
ure 4b, the so-called parallel X (pX)) and 26 had a Y con-
figuration so that the DNA 'tails' formed a single branch
(Figure 4b; parallel Y (pY)). The measured Lse of the pX
and pY complexes was 30 ± 15 nm and 27 ± 15 nm,
respectively, compatible with complexes in which exter-
nal flanking DNA is never paired but the internal flanking
DNA is paired in the pY population.
Taken together, these results suggest that OrfAB[1-149]
promotes the formation of parallel paired DNA molecule
complexes, and it seems probable that synaptic complex
A of IS911  generated by the full-length transposase
would also assume this configuration. We believe that theRousseau et al. Mobile DNA 2010, 1:16
http://www.mobilednajournal.com/content/1/1/16
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minor fraction of apparently antiparallel structures con-
sists of nonspecific products rather than real synaptic
complexes.
Discussion
The asymmetric two-step transposition mechanism
adopted by IS911 (Figure 1a) is one of the most exten-
sively used pathways by known ISs. In addition to the IS3
family (505 members identified; http://www-is.biotoul.fr)
to which IS911 belongs, members of the IS21 (130 mem-
bers), IS30 (78 members) and IS256 (113 members) fami-
lies also appear to use similar mechanisms [12-15]. This
contrasts with the other transposition paradigms of both
prokaryotic (IS10, IS50, Tn7) and eukaryotic (mariner,
Figure 4 AFM imaging of IRR-OrfAB[1-149] complexes. (A) Images obtained for a 250 bp DNA fragment carrying a right inverted repeat (IRR), with 
or without incubation with OrfAB[1-149]. (B) Examples of structures observed between OrfAB[1-149] and DNA. DNA is represented as in figures 2-4 as 
large cylinders (IRR) and small cylinders (flanking DNA). The different structures are: pX = parallel X; pY = parallel Y; Ap = anti-parallel (see text). The 
Number (n) and percentage of these complexes are given. (C) Organisation of the DNA fragment is represented with theoretical lengths: Ltot is the 
total length and Lse is the length from the end of the DNA fragment to the OrfAB[1-149] binding site within IRR (Figure 1c).Rousseau et al. Mobile DNA 2010, 1:16
http://www.mobilednajournal.com/content/1/1/16
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hermes, PiggyBac) origin, which shed their flanking DNA
without forming a covalently circular intermediate, and
of bacteriophage Mu and members of the Tn3 transposon
family, which retain their DNA flanks during transposi-
tion to generate co-integrated intermediates with fused
donor and target molecules [26-28].
The IS911  model therefore represents an important
and widespread transposition paradigm. Because the
IS911 transposase (OrfAB) like most transposases of this
type, has to date proved refractory to structural analysis
by classic X-ray crystallography and nuclear magnetic
resonance approaches, we adopted alternative methods
here to probe the organisation of the IS911 transposo-
some. We used a minimal DNA fragment of 36 bp consti-
tuting the right terminal IS911 inverted repeat, IRR and
analysed the formation of protein-DNA complexes (Fig-
ure 2). With this short DNA, OrfAB[1-149], a C-terminal
truncated OrfAB derivative carrying the first 149 amino
acids (Figure 1b), appeared unable to form synaptic com-
plex A, in which the two ends are bridged by the trun-
cated transposase derivative. Using larger DNA
fragments (carrying flanking DNA on each end of IRR),
SCA were readily observed with OrfAB[1-149] [21]. Gel
retardation with OrfAB[1-149] and an OrfAB[1-149]
derivative with an N-terminal TrxA extension indicated
that OrfAB[1-149] was present as a dimer. A mixture of
both OrfAB[1-149] and TrxA-OrfAB[1-149] generated a
single additional band compared with those generated by
the two proteins separately (Figure 2). These experiments
also revealed that the 36 bp DNA fragment showed poor
affinity for the proteins and suggested that the TrxA-
OrfAB[1-149] derivative bound even less avidly, presum-
ably as a result of steric hindrance due to the presence of
the TrxA tag.
Importantly, the degree of migration of the three com-
plexes was consistent with their proposed composition:
complex I, the OrfAB[1-149] dimer; complex II, the
OrfAB[1-149]+TrxA-OrfAB[1-149], and complex III, the
TrxA-OrfAB[1-149] dimer. Results using larger DNA
fragments (Figure 3) suggested that SCA also includes
two OrfAB[1-149] molecules, although the migration of
the complexes could not be used to determine their
molecular mass. This is presumably due to the presence
of additional flanking DNA that acts to increase the sta-
bility of the protein-DNA complex. The additional pro-
tein-DNA interactions that may occur to achieve this may
change DNA configuration (for example, by bending or
wrapping the DNA round the protein) and therefore exert
a major influence on complex migration through the gel
[8,24].
Having established that two OrfAB[1-149] monomers
bridge the two IRR-containing DNA fragments, we initi-
ated AFM studies in an attempt to determine the configu-
ration of DNA molecules in these complexes. W e were
able to demonstrate that the addition of OrfAB[1-149] to
a 250 bp DNA carrying an IRR resulted in a very signifi-
cant increase in the percentage of paired DNA (24% ver-
sus 6%). Moreover, because the position of the OrfAB[1-
149] binding site was asymmetric, we were able to assess
whether the DNA in these complexes was in a parallel or
an antiparallel configuration. As judged by this two-
dimensional imaging technique, the vast majority of these
potential synaptic complexes appeared to contain DNA
in a parallel configuration. They showed two types of
morphology: either Y- (pY) or X-like (pX). In both cases,
the position corresponding to the OrfAB[1-149] binding
site within IRR was paired whereas the external flanking
DNA was always unpaired. The difference between pX
and pY depends on whether the DNA portion corre-
sponding to the internal flanking DNA is paired or not;
this DNA is part of IS911 but not part of IRR. Our failure
to clearly observe OrfAB[1-149] by AFM might be due to
its small size (17.5 kDa) and the involvement of only one
protein dimer per SCA as shown above. It could also stem
from a partial disruption of the proteins from the DNA
during dilution and deposition of the complexes, even
though the polylysine-treated mica support is expected to
trap the DNA instantly [29].
This result is consistent with the observation obtained
from measurement of the relative efficiencies of synaptic
complex formation/stability between inverted and
directly repeated pairs of IS911 ends. Using tethered par-
ticle motion to measure the length of a tethered DNA
molecule by the trace of a bead attached to its free end,
we showed that although OrfAB[1-149] can bridge two
directly repeated ends (measured by the shortening due
to the resulting DNA loop), it does so with less efficiency
than for a DNA substrate carrying inverted ends [30].
The observed dynamics of SCA formation were more
compatible with parallel rather than antiparallel pairing
of IRR and IRL in the SCA. Both this and the result
obtained using AFM suggest that the ends are brought
together in a parallel configuration.
These observations on SCA organisation are in agree-
ment with previously proposed models based on EMSA,
DNAse protection and deletion experiments [21]. We
propose that a dimer of OrfAB[1-149] binds and bridges a
subterminal region within inverted repeats (IRR and IRL)
to form the SCA. This explains the functional importance
of the LZ and M multimerisation domains of OrfAB[1-
149], which cannot be mutated or deleted without
destroying specific DNA binding activity of the protein
[22]. The fact that the external region of IRR and the
external flanking DNA were never observed to be bridged
in the AFM images and are not protected against DNase I
in footprinting experiments [21] implies that the terminal
regions of the IR are free for contacts with the catalytic
domain of OrfAB, which is absent in OrfAB[1-149]. ThisRousseau et al. Mobile DNA 2010, 1:16
http://www.mobilednajournal.com/content/1/1/16
Page 8 of 8
type of configuration would also permit trans cleavage, as
observed for IS50  [9] and bacteriophage Mu [10], in
which the catalytic domain of one transposase molecule
bound at one end is directed to cleave the opposite IS
end. Experiments are in progress to test these predic-
tions.
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